• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素与氯霉素对血流感染中耐万古霉素粪肠球菌(VREfm)分离株的协同作用。

Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.

机构信息

Department of Life Sciences, University of Trieste, Trieste, Italy.

Department of Sciences, "Roma Tre" University, Rome, Italy.

出版信息

Diagn Microbiol Infect Dis. 2021 Feb;99(2):115241. doi: 10.1016/j.diagmicrobio.2020.115241. Epub 2020 Oct 15.

DOI:10.1016/j.diagmicrobio.2020.115241
PMID:33130503
Abstract

Vancomycin-resistant Enterococcus faecium (VREfm) infections are increasing. Current anti-VREfm options (linezolid and daptomycin) are suboptimal. Fosfomycin maintains good efficacy against VREfm and chloramphenicol is active against ≥ 90% of VREfm. We tested chloramphenicol + fosfomycin (CAF+FOS) against 10 VREfm isolated from blood. MICs were 64 to 512 µg/mL for fosfomycin and 8 to 16 µg/mL for chloramphenicol. The combination decreased both MICs, with a synergic effect in 50% of the isolates and an additive effect in the remaining 50%. Time-kill assays performed on fractional inhibitory concentration index ≤ 0.5 strains confirmed the synergism. The antibiotic combination at ¼ of minimum inhibitory concentrations (MICs) caused a ≥ 2 log reduction compared to the two antibiotics alone. Finally, we provided a proof of concept of the in vitro efficacy of CAF+FOS in G. mellonella. The survival of G. mellonella larvae treated with the combination was significantly higher. The activity of fosfomycin and chloramphenicol against VREfm increases when they are used in combination.

摘要

屎肠球菌(VREfm)感染正在增加。目前针对 VREfm 的可选药物(利奈唑胺和达托霉素)并不理想。磷霉素对 VREfm 仍保持良好的疗效,而氯霉素对 90%以上的 VREfm 具有活性。我们检测了氯霉素+磷霉素(CAF+FOS)对从血液中分离出的 10 株 VREfm 的作用。磷霉素的 MIC 值为 64 至 512 µg/mL,氯霉素的 MIC 值为 8 至 16 µg/mL。该组合降低了两种药物的 MIC 值,在 50%的分离株中表现出协同作用,在其余 50%的分离株中表现出相加作用。在分数抑菌浓度指数≤0.5 的菌株上进行的时间杀伤试验证实了协同作用。与两种抗生素单独使用相比,联合使用最低抑菌浓度(MIC)的四分之一浓度可导致 2 个对数减少。最后,我们在 G. mellonella 中提供了 CAF+FOS 体外疗效的概念验证。接受联合治疗的 G. mellonella 幼虫的存活率显著提高。当磷霉素和氯霉素联合使用时,它们对 VREfm 的活性增加。

相似文献

1
Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.磷霉素与氯霉素对血流感染中耐万古霉素粪肠球菌(VREfm)分离株的协同作用。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115241. doi: 10.1016/j.diagmicrobio.2020.115241. Epub 2020 Oct 15.
2
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).血流感染的耐万古霉素屎肠球菌对依拉环素、奥马环素、脂糖肽类及其他对照抗生素的药敏性:2019 - 2020年台湾地区多中心抗菌药物耐药性全国监测(SMART)结果
Int J Antimicrob Agents. 2021 Jul;58(1):106353. doi: 10.1016/j.ijantimicag.2021.106353. Epub 2021 May 5.
3
In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.基于磷霉素的联合用药在体外对临床耐万古霉素肠球菌分离株的疗效。
Diagn Microbiol Infect Dis. 2013 Nov;77(3):254-7. doi: 10.1016/j.diagmicrobio.2013.07.012. Epub 2013 Sep 9.
4
Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.10 年间,从印度分离的多药耐药肠球菌门诊分离株对呋喃妥因和磷霉素的敏感性。
Microb Drug Resist. 2020 Dec;26(12):1509-1515. doi: 10.1089/mdr.2019.0044. Epub 2019 Dec 2.
5
Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an Pharmacokinetic/Pharmacodynamic Model of Infection.单次剂量奥他万古霉素与每日高剂量达托霉素方案治疗耐万古霉素粪肠球菌感染的比较药效动力学/药效动力学模型研究。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01265-17. Print 2017 Oct.
6
Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an Pharmacokinetic/Pharmacodynamic Model.评估利奈唑胺在治疗耐万古霉素粪肠球菌中的疗效
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01873-17. Print 2018 Jan.
7
Molecular characterization of vancomycin-resistant enterococci isolated from a hospital in Beijing, China.中国北京一家医院分离的万古霉素耐药肠球菌的分子特征。
J Microbiol Immunol Infect. 2019 Jun;52(3):433-442. doi: 10.1016/j.jmii.2018.12.008. Epub 2019 Feb 11.
8
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.磷霉素与阿莫西林、达托霉素和利奈唑胺联合体外抗肾移植患者感染性尿支架中万古霉素耐药粪肠球菌。
Antimicrob Agents Chemother. 2013 Mar;57(3):1518-20. doi: 10.1128/AAC.02099-12. Epub 2012 Dec 21.
9
Clinically Applicable System for Rapidly Predicting Enterococcus faecium Susceptibility to Vancomycin.临床适用的快速预测粪肠球菌对万古霉素敏感性的系统。
Microbiol Spectr. 2021 Dec 22;9(3):e0091321. doi: 10.1128/Spectrum.00913-21. Epub 2021 Nov 10.
10
Establishment and Persistence of Glycopeptide-Resistant ST80 and ST117 Clones Within a Health Care Facility Located in a Low-Prevalence Geographical Region.在低流行地理区域的医疗机构中耐糖肽 ST80 和 ST117 克隆的建立和持续存在。
Microb Drug Resist. 2022 Feb;28(2):217-221. doi: 10.1089/mdr.2021.0171. Epub 2021 Oct 27.

引用本文的文献

1
Pathogenicity potential of enterococci isolated from a Veterinary Biological Isolation and Containment Unit.从兽医生物隔离与防护单元分离出的肠球菌的致病潜力。
Front Vet Sci. 2024 Oct 21;11:1458069. doi: 10.3389/fvets.2024.1458069. eCollection 2024.
2
Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review.解读抗生素-药物相互作用框架中的复杂相互作用:一篇叙述性综述
Antibiotics (Basel). 2024 Oct 5;13(10):938. doi: 10.3390/antibiotics13100938.
3
Synergistic properties of linezolid against Enterococcus spp. isolates: a systematic review from in vitro studies.
利奈唑胺对肠球菌属分离株的协同作用:来自体外研究的系统评价。
Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):17-31. doi: 10.1007/s10096-023-04704-8. Epub 2023 Nov 17.
4
Bacteriophage vB_EfaH_163, a New Member of the Family, Reduces the Mortality Associated with an vanR Clinical Isolate in a Animal Model.噬菌体能有效抑制临床分离 vanR 阳性大肠杆菌的毒力
Viruses. 2023 Jan 7;15(1):179. doi: 10.3390/v15010179.
5
In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant .奥利万星与磷霉素对耐万古霉素菌协同作用的体外和体内研究
Antibiotics (Basel). 2022 Sep 29;11(10):1334. doi: 10.3390/antibiotics11101334.
6
Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant .评估体外和体内耐药性的出现:利奈唑胺联合磷霉素对磷霉素敏感和耐药菌株的作用
Infect Drug Resist. 2022 Aug 30;15:4995-5010. doi: 10.2147/IDR.S377848. eCollection 2022.